{"nct_id":"NCT04422912","title":"A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)","status":"RECRUITING","status_verified_date":"2025-03","start_date":"2020-09-29","start_date_type":"ACTUAL","primary_completion_date":"2029-01","primary_completion_date_type":"ESTIMATED","completion_date":"2029-01","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["CABA"]}